Does BINIMETINIB Cause Neoplasm progression? 387 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 387 reports of Neoplasm progression have been filed in association with BINIMETINIB (MEKTOVI). This represents 5.6% of all adverse event reports for BINIMETINIB.
387
Reports of Neoplasm progression with BINIMETINIB
5.6%
of all BINIMETINIB reports
122
Deaths
88
Hospitalizations
How Dangerous Is Neoplasm progression From BINIMETINIB?
Of the 387 reports, 122 (31.5%) resulted in death, 88 (22.7%) required hospitalization, and 6 (1.6%) were considered life-threatening.
Is Neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BINIMETINIB. However, 387 reports have been filed with the FAERS database.
What Other Side Effects Does BINIMETINIB Cause?
Off label use (902)
Death (719)
Nausea (657)
Fatigue (562)
Diarrhoea (521)
Product use in unapproved indication (508)
Pyrexia (490)
Vomiting (375)
Rash (360)
Serous retinal detachment (299)
What Other Drugs Cause Neoplasm progression?
PALBOCICLIB (10,885)
SUNITINIB MALATE (1,920)
CYCLOPHOSPHAMIDE (1,588)
CARBOPLATIN (1,370)
AXITINIB (1,315)
DOXORUBICIN (1,276)
LETROZOLE (1,225)
PACLITAXEL (1,180)
CRIZOTINIB (1,161)
VINCRISTINE (1,106)
Which BINIMETINIB Alternatives Have Lower Neoplasm progression Risk?
BINIMETINIB vs BIOFLAVONOIDS
BINIMETINIB vs BIOTIN
BINIMETINIB vs BIPERIDEN
BINIMETINIB vs BIRCH TRITERPENES
BINIMETINIB vs BISACODYL